Published in Medical Letter on the CDC and FDA, November 5th, 2006
Heaton joins the company after a seven-year career at Merck & Co.'s Research Laboratories, where she served as senior director of Vaccines Clinical Research.
She will be responsible for all medical and regulatory affairs and will lead the clinical development programs for Novavax's pandemic and seasonal influenza vaccines. Heaton will report directly to Novavax President and Chief Executive Officer Dr. Rahul Singhvi.
While at Merck, Heaton, 42, oversaw the clinical development and global regulatory filings and approval process for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.